The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase IB study of tovorafenib for children with relapsed/recurrent low-grade gliomas and other MAPK pathway activated tumors.
 
Karen D. Wright
No Relationships to Disclose
 
Cassie Kline
Research Funding - Bristol-Myers Squibb (Inst); Chimerix (Inst); Curis (Inst); Day One Therapeutics (Inst); Ipsen (Inst); Kazia Therapeutics (Inst); Midatech Pharma (Inst); Regeneron (Inst)
 
Mohamed Shebl Abdelbaki
Consulting or Advisory Role - Bexion; Day One Biopharmaceuticals; Day One pharmaceuticals
Speakers' Bureau - Day One Biopharmaceuticals
Research Funding - Novartis
 
Elias Sayour
Patents, Royalties, Other Intellectual Property - Patent applications for immunotherapeutic targeting of cancer using approaches/technologies developed in our lab
 
David Ebb
No Relationships to Disclose
 
Matthew Miller
No Relationships to Disclose
 
Erin Crotty
No Relationships to Disclose
 
Ashley S. Margol
Consulting or Advisory Role - Day One Biopharmaceuticals
 
Lindsay Kilburn
No Relationships to Disclose
 
Kenneth J. Cohen
Consulting or Advisory Role - Bristol-Myers Squibb; DNAtrix; Novartis
Research Funding - Bristol-Myers Squibb; Novartis
 
Anne Elizabeth Bendel
No Relationships to Disclose
 
Jennifer Elster
No Relationships to Disclose
 
Lianne Greenspan
No Relationships to Disclose
 
Pei-Chi Kao
No Relationships to Disclose
 
Clement Ma
No Relationships to Disclose
 
Wendy London
No Relationships to Disclose
 
Michael Prados
Stock and Other Ownership Interests - Quadriga Biosciences
Research Funding - Bristol-Myers Squibb (Inst); Day One Therapeutics (Inst); Genentech/Roche (Inst); Novartis (Inst); Oncoceutics (Inst); Regeneron (Inst)
 
Daphne A. Haas-Kogan
Employment - Brigham and Women's Hospital; Dana Farber Cancer Hospital
Leadership - EmpNia; Graegis Pharmaceuticals SAB; TeleRad Oncology
Honoraria - Cincinnati Children's Hospital DSMC; DEFENSE FINANCE SERVICE AGENT DHHS; General Dynamic Information Tech, Inc. Reviewer; St. Jude Children’s Research Hospital
Consulting or Advisory Role - Gerson Lehrman Group; Guidepoint Global
Research Funding - Artios
Expert Testimony - Bendin, Sumrall @ Ladner, LLC; Bowman and Brooke, LLP; The EMMES Company, LLC
 
Sabine Mueller
Consulting or Advisory Role - Roche
Research Funding - Blueprint Medicines (Inst); Bristol Meyer Scribbs (Inst); Chimerix (Inst); Curis Pharamceuticals (Inst); DayOne Pharmaceuticals (Inst); Pfizer (Inst); Regeneron (Inst); SonaCare Medical (Inst)